We recently published 11 Latest Stocks Jim Cramer Talked About. Kimberly-Clark Corporation (NASDAQ:KMB) is one of the stocks ...

We recently published 11 Latest Stocks Jim Cramer Talked About. Kenvue Inc. (NYSE:KVUE) is one of the stocks Jim Cramer ...

Kimberly-Clark Corporation (NASDAQ: KMB) is one of the stocks Jim Cramer recently commented on. Cramer highlighted the ...

In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 ...

On Nov. 3rd, Wall Street rendered a swift and brutal verdict on Kimberly-Clark's (NASDAQ: KMB) transformative acquisition of ...

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, Kimberly-Clark’s $40 billion Kenvue deal, and more.

Shares in consumer health group Kimberly-Clark ($KMB) dropped again today as a leading analyst downgraded the stock after its ...

Dr. AJ Sumell, economics professor at Youngstown State University, said it's still to be determined just how many jobs other ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

This issue will look a little different. It will read more like the weekly updates I send to my premium Yield Shark readers.

U.S. futures followed global markets higher ahead of another big week of corporate earnings reports but an absence of economic data as the U.S. government shutdown entered its second month ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.